Singapore markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
39.68+0.72 (+1.85%)
As of 10:32AM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-460,468
-432,842
-351,511
-225,334
-152,142
Depreciation & amortisation
5,847
5,627
4,903
2,731
397
Stock-based compensation
77,750
69,410
38,780
23,941
10,521
Change in working capital
21,552
16,113
28,064
15,541
17,707
Accounts payable
3,612
2,038
-763
7,278
1,417
Other working capital
-370,790
-346,109
-297,141
-189,049
-136,694
Other non-cash items
8,892
19,091
-6,874
672
2,445
Net cash provided by operating activities
-367,047
-342,301
-293,187
-178,546
-117,802
Cash flows from investing activities
Investments in property, plant and equipment
-3,743
-3,808
-3,954
-10,503
-18,892
Purchases of investments
-800,288
-865,270
-887,737
-425,158
0
Sales/maturities of investments
786,135
942,800
502,857
0
-
Net cash used for investing activities
-17,896
73,722
-388,834
-435,661
-18,892
Cash flows from financing activities
Common stock issued
-
498,944
238,263
328,251
0
Other financing activities
-
31,111
37,102
30,895
440,835
Net cash used provided by (used for) financing activities
551,656
548,616
623,191
423,602
440,835
Net change in cash
166,713
280,037
-58,830
-190,605
304,141
Cash at beginning of period
155,683
138,388
197,218
387,823
83,682
Cash at end of period
322,396
418,425
138,388
197,218
387,823
Free cash flow
Operating cash flow
-367,047
-342,301
-293,187
-178,546
-117,802
Capital expenditure
-3,743
-3,808
-3,954
-10,503
-18,892
Free cash flow
-370,790
-346,109
-297,141
-189,049
-136,694